Demyelinating disease in SLE: Is it multiple sclerosis or lupus?

Waxman, 1998, Demyelinating diseases–new pathological insights, new therapeutic targets, New England Journal of Medicine, 338, 323

Noseworthy, 2000, Multiple sclerosis, New England Journal of Medicine, 343, 938, 10.1056/NEJM200009283431307

Miller, 2008, Differential diagnosis of suspected multiple sclerosis: a consensus approach, Multiple Sclerosis, 14, 1157, 10.1177/1352458508096878

Miller, 2012, Clinically isolated syndromes, Lancet Neurology, 11, 157, 10.1016/S1474-4422(11)70274-5

Theodoridou, 2006, Demyelination in rheumatic diseases, Journal of Neurology, Neurosurgery, and Psychiatry, 77, 290

1999, The American College Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes, Arthritis & Rheumatism, 42, 599, 10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F

Hanly, 2007, Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study, Arthritis & Rheumatism, 56, 265, 10.1002/art.22305

Borowoy, 2012, Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort, Seminars in Arthritis and Rheumatism, 42, 179, 10.1016/j.semarthrit.2012.03.011

Bertsias, 2010, Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations, Nature Reviews Rheumatology, 6, 358, 10.1038/nrrheum.2010.62

Unterman, 2011, Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis, Seminars in Arthritis and Rheumatism, 41, 1, 10.1016/j.semarthrit.2010.08.001

Kampylafka, 2013, Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3 year prospective study of 370 patients, PLoS One, 8, e55843, 10.1371/journal.pone.0055843

Johnson, 1995, The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth, Arthritis & Rheumatism, 38, 551, 10.1002/art.1780380415

Ferreira, 2005, Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?, Rheumatology (Oxford), 44, 434, 10.1093/rheumatology/keh532

Hanly, 2011, Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus, Annals of the Rheumatic Diseases, 70, 1726, 10.1136/ard.2010.148502

Jennekans, 2002, The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms in clinical syndromes: a literature investigation, Rheumatology (Oxford), 41, 619, 10.1093/rheumatology/41.6.619

Karussis, 1998, A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?, Annals of Neurology, 44, 629, 10.1002/ana.410440408

IJdo, 1999, Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?, Lupus, 8, 109, 10.1191/096120399678847461

Cuadrado, 2000, Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature, Medicine (Baltimore), 79, 57, 10.1097/00005792-200001000-00006

Ruiz-Irastorza, 2000, Warfarin for multiple sclerosis?, Quarterly Journal of Medicine, 93, 497, 10.1093/qjmed/93.8.497

Feng, 2012, Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis, Journal of the Neurological Sciences, 313, 48, 10.1016/j.jns.2011.09.032

Kimura, 2008, Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI, Lupus, 17, 16, 10.1177/0961203307085112

Filippi, 2012, Association between pathological and MRI findings in multiple sclerosis, Lancet Neurology, 11, 349, 10.1016/S1474-4422(12)70003-0

Brooks, 2010, The histopathologic associates of neurometabolite abnormalities in fatal neuropsychiatric systemic lupus erythematosus, Arthritis & Rheumatism, 62, 2055, 10.1002/art.27458

Sibbitt, 2010, Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus, Seminars in Arthritis and Rheumatism, 40, 32, 10.1016/j.semarthrit.2009.08.005

Steup-Beekman, 2013, Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause, Annals of the Rheumatic Diseases, 72, ii76, 10.1136/annrheumdis-2012-202369

Charil, 2006, MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation", Lancet Neurology, 5, 841, 10.1016/S1474-4422(06)70572-5

Luyendijk, 2011, Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging, Arthritis & Rheumatism, 63, 722, 10.1002/art.30157

Bertsias, 2010, EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs, Annals of the Rheumatic Diseases, 69, 2074, 10.1136/ard.2010.130476

Karassa, 2000, Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus, American Journal of Medicine, 109, 628, 10.1016/S0002-9343(00)00603-3

Chard, 2002, Brain atrophy in clinically early relapsing-remitting multiple sclerosis, Brain, 125, 327, 10.1093/brain/awf025

Filippi, 2011, MR imaging of multiple sclerosis, Radiology, 259, 659, 10.1148/radiol.11101362

Emmer, 2010, Perfusion MRI in neuro-psychiatric systemic lupus erythematosus, Journal of Magnetic Resonance Imaging, 32, 283, 10.1002/jmri.22251

Gasparovic, 2010, Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging, Journal of Rheumatology, 37, 1834, 10.3899/jrheum.091276

Bosma, 2000, Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus using volumetric magnetization transfer imaging, Arthritis & Rheumatism, 43, 2428, 10.1002/1529-0131(200011)43:11<2428::AID-ANR9>3.0.CO;2-H

Mehta, 1996, Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema, American Journal of Neuroradiology, 17, 1051

Schmierer, 2004, Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain, Annals of Neurology, 56, 407, 10.1002/ana.20202

Dehmeshki, 2002, Systemic lupus erythematosus: diagnostic application of magnetization transfer ratio histograms in patients with neuropsychiatric symptoms-initial results, Radiology, 222, 722, 10.1148/radiol.2223010413

Peterson, 2005, Imaging in CNS lupus, Best Practice & Research Clinical Rheumatology, 19, 727, 10.1016/j.berh.2005.04.001

Emmer, 2010, Tract-based spatial statistics on diffusion tensor imaging in systemic lupus erythematosus reveals localized involvement of white matter tracts, Arthritis & Rheumatism, 62, 3716, 10.1002/art.27717

Bakshi, 1998, High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis, Journal of Neuroimaging, 8, 228, 10.1111/jon199884228

Weiner, 2000, Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET, Annals of the Rheumatic Diseases, 59, 377, 10.1136/ard.59.5.377

Kiferle, 2011, Positron emission tomography imaging in multiple sclerosis-current status and future applications, European Journal of Neurology, 18, 226, 10.1111/j.1468-1331.2010.03154.x

Assadi, 2010, Brain single photon emission computed tomography with Tc-99m MIBI or Tc-99m ECD in comparison to MRI in multiple sclerosis, Clinical Nuclear Medicine, 35, 682, 10.1097/RLU.0b013e3181e9fa7a

Driver, 2008, Clinical validation of the watershed sign as a marker for neuropsychiatric systemic lupus erythematosus, Arthritis & Rheumatism, 59, 332, 10.1002/art.23308

Costallat, 1997, Evoked potentials in the assessment of neuropsychiatric manifestations in systemic lupus erythematosus, Clinical Rheumatology, 16, 217, 10.1007/BF02247855

Paran, 2006, Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis, Annals of the Rheumatic Diseases, 65, 525, 10.1136/ard.2005.040352

Bhat, 2010, The epidemiology of transverse myelitis, Autoimmunity Reviews, 9, A395, 10.1016/j.autrev.2009.12.007

Sanna, 2008, Neuropsychiatric involvement in systemic lupus erythematosus: current therapeutic approach, Current Pharmaceutical Design, 14, 1261, 10.2174/138161208799316401

Kovacs, 2000, Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature, Annals of the Rheumatic Diseases, 59, 120, 10.1136/ard.59.2.120

D'Cruz, 2004, Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies, Journal of Rheumatology, 31, 280

Espinosa, 2010, Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients, Seminars in Arthritis and Rheumatism, 39, 246, 10.1016/j.semarthrit.2008.09.002

Mok, 1998, Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome, Journal of Rheumatology, 25, 467

Lu, 2008, Prognostic factors of lupus myelopathy, Lupus, 17, 323, 10.1177/0961203307088005

Katsiari, 2011, Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation, European Journal of Neurology, 18, 556, 10.1111/j.1468-1331.2010.03208.x

Birnbaum, 2009, Distinct subtypes of myelitis in systemic lupus erythematosus, Arthritis & Rheumatism, 60, 3378, 10.1002/art.24937

Provenzale, 1994, Lupus-related myelitis: serial MR findings, American Journal of Neuroradiology, 15, 1911

Trebst, 2011, Longitudinal extensive transverse myelitis–it's not all neuromyelitis optica, Nature Reviews Neurology, 7, 688, 10.1038/nrneurol.2011.176

Lin, 2009, Systemic lupus erythematosus-associated optic neuritis: clinical experience and literature review, Acta Ophthalmologica, 87, 204, 10.1111/j.1755-3768.2008.01193.x

Smith, 2005, Optic neuritis, vol. 1, 293

Wingerchuk, 2012, The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease, Multiple Sclerosis, 18, 5, 10.1177/1352458511431077

Polgár, 2011, Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping cases, Autoimmunity Reviews, 10, 171, 10.1016/j.autrev.2010.09.021

Fernandes Moça Trevisani, 2013, Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus, Cochrane Database of Systematic Reviews, 2, CD002265

Neuwelt, 2003, The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus, Therapeutic Apheresis and Dialysis, 7, 173, 10.1046/j.1526-0968.2003.00032.x

Narváez, 2011, Rituximab therapy in refractory neuropsychiatric lupus: current clinical evidence, Seminars in Arthritis and Rheumatism, 41, 364, 10.1016/j.semarthrit.2011.06.004

Ruiz-Irastorza, 2007, A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies, Arthritis & Rheumatism, 57, 1487, 10.1002/art.23109

Scott, 2011, Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology, Neurology, 77, 2128, 10.1212/WNL.0b013e31823dc535

Ye, 2011, Rituximab in the treatment of severe lupus myelopathy, Clinical Rheumatology, 30, 981, 10.1007/s10067-011-1714-5

Karim, 2009, Devic's syndrome as initial presentation of systemic lupus erythematosus, American Journal of the Medical Sciences, 338, 245, 10.1097/MAJ.0b013e3181a8be1d

Molloy, 2012, Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies, Arthritis & Rheumatism, 64, 3043, 10.1002/art.34468

Molloy, 2008, Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?, Autoimmunity Reviews, 8, 144, 10.1016/j.autrev.2008.07.006